Home > Products > CD3 & CLEC12A
> Human Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-IgG)
Human Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H247)
Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-CD3 and anti-CLEC12A parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Myelodysplastic syndromes (MDS); Chronic myelogenous leukemia (CML) therapy.
There are currently no customer reviews or questions for Human Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-IgG) (BSIG-H247). Click the button below to contact us or submit your feedback about this product.